Surge Therapeutics

SURGE Therapeutics Aims to Significantly Improve Survival Rates for Cancer Patients by Disrupting the Delivery, Timing, and Location of Cancer Immunotherapy. The company is developing an injectable, biodegradable hydrogel capable of prolonging and locally releasing cancer immunotherapy at the site of surgical tumor removal.